4Perrillo R, et al. Hepatology, 1999; 29(5): 1581-1586.
5Fontana RJ, et al. Liver Transpl, 2001; 7(6):504-510.
6Mutimer D, et al. Gut, 20001.46:107.
7Mutimer D, et al. J Hepatol, 1999; 30:715-721.
8Perrillo R, et al. Hepatology, 2001 ;33: 424-432.
9Liaw YF, et al. Hepatology,.19991 30(2):567-572.
10Leung N, et al. J Med Virol, 20001 61:380-385.
同被引文献4
1Leemans WF, Janssen HL, Niesters HG, et al. Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression. Viral Hepat, 2008,15(2) :108.
2Jung JK, Lee CH, Kim EY, et al. Change of HBV DNA level as a predictor of HBeAg loss after larnivudine treatment,Korean J Hepatol, 2007,13(4) :513.
